Year: 1998
Type: article
Abstract: To the Editor: Troglitazone is a thiazolidine 2,4-dione derivative that represents a novel class of oral drugs for the treatment of diabetes. In clinical trials, including two published in this iss...
Source: New England Journal of Medicine
Authors: Paul B. Watkins, Randall W. Whitcomb
Institution: University of Michigan
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2003856834